Long-term outcomes of a cultured autologous dermo-epidermal skin substitute in children: 5-year results of a phase I clinical trial

Limited donor sites and poor long-term outcomes with standard treatment for large skin defects remain a huge problem. An autologous, bilayered, laboratory-grown skin substitute (denovoSkin) was developed to overcome this problem and has shown to be safe in 10 pediatric patients in a Phase I clinical...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Schiestl, Clemens (VerfasserIn) , Neuhaus, Kathrin (VerfasserIn) , Meuli, Martin (VerfasserIn) , Farkas, Melinda (VerfasserIn) , Hartmann-Fritsch, Fabienne (VerfasserIn) , Elrod, Julia (VerfasserIn) , Bressan, Jenny (VerfasserIn) , Reichmann, Ernst (VerfasserIn) , Böttcher-Haberzeth, Sophie (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 08 August 2024
In: Journal of burn care & research
Year: 2024, Pages: 1-9
ISSN:1559-0488
DOI:10.1093/jbcr/irae150
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1093/jbcr/irae150
Volltext
Verfasserangaben:Clemens Schiestl, MD, Kathrin Neuhaus, MD, Martin Meuli, MD, Melinda Farkas, PhD, Fabienne Hartmann-Fritsch, PhD, Julia Elrod, MD, Jenny Bressan, Ernst Reichmann, PhD, Sophie Böttcher-Haberzeth, MD

MARC

LEADER 00000caa a22000002c 4500
001 1905080158
003 DE-627
005 20241205180005.0
007 cr uuu---uuuuu
008 241008s2024 xx |||||o 00| ||eng c
024 7 |a 10.1093/jbcr/irae150  |2 doi 
035 |a (DE-627)1905080158 
035 |a (DE-599)KXP1905080158 
035 |a (OCoLC)1475314743 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Schiestl, Clemens  |d 1958-  |e VerfasserIn  |0 (DE-588)114477477  |0 (DE-627)572467389  |0 (DE-576)289798361  |4 aut 
245 1 0 |a Long-term outcomes of a cultured autologous dermo-epidermal skin substitute in children  |b 5-year results of a phase I clinical trial  |c Clemens Schiestl, MD, Kathrin Neuhaus, MD, Martin Meuli, MD, Melinda Farkas, PhD, Fabienne Hartmann-Fritsch, PhD, Julia Elrod, MD, Jenny Bressan, Ernst Reichmann, PhD, Sophie Böttcher-Haberzeth, MD 
264 1 |c 08 August 2024 
300 |b Illustrationen 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 08.10.2024 
520 |a Limited donor sites and poor long-term outcomes with standard treatment for large skin defects remain a huge problem. An autologous, bilayered, laboratory-grown skin substitute (denovoSkin) was developed to overcome this problem and has shown to be safe in 10 pediatric patients in a Phase I clinical trial after transplantation. The goal of this article was to report on 48-month long-term results. The pediatric participants of the phase I clinical trial were followed up at yearly visits up to 5 years after transplantation. Safety parameters, including the occurrence of adverse events, possible deviations of vital signs, and changes in concomitant therapy as well as additional parameters regarding skin stability, scar quality, and tumor formation, were assessed. Furthermore, scar maturation was photographically documented. Of the 10 patients treated with denovoSkin in this phase I clinical trial, 7 completed the 5-year follow-up period. Skin substitutes continued to be deemed safe, remained stable, and practically unchanged, with no sign of fragility and no tumor formation at clinical examination. Scar quality, captured using the Patient and Observer Scar Assessment Scale, was evaluated as close to normal skin. Transplantation of this laboratory-grown skin substitute in children is to date considered safe and shows encouraging functional and aesthetical long-term results close to normal skin. These results are promising and highlight the potential of a life-saving therapy for large skin defects. A multicentre, prospective, randomized, phase II clinical trial is currently ongoing to further evaluate the safety and efficacy of this novel skin substitute. Clinicaltrials.gov identifier NCT02145130. 
700 1 |a Neuhaus, Kathrin  |d 1977-  |e VerfasserIn  |0 (DE-588)1025241584  |0 (DE-627)721906168  |0 (DE-576)370107284  |4 aut 
700 1 |a Meuli, Martin  |d 1955-  |e VerfasserIn  |0 (DE-588)1137873809  |0 (DE-627)895164736  |0 (DE-576)491835558  |4 aut 
700 1 |a Farkas, Melinda  |d 1982-  |e VerfasserIn  |0 (DE-588)1295011239  |0 (DE-627)1851823867  |4 aut 
700 1 |a Hartmann-Fritsch, Fabienne  |d 1983-  |e VerfasserIn  |0 (DE-588)1116520508  |0 (DE-627)871199882  |0 (DE-576)47845595X  |4 aut 
700 1 |a Elrod, Julia  |d 1987-  |e VerfasserIn  |0 (DE-588)1094920886  |0 (DE-627)855379847  |0 (DE-576)462865916  |4 aut 
700 1 |a Bressan, Jenny  |e VerfasserIn  |4 aut 
700 1 |a Reichmann, Ernst  |e VerfasserIn  |4 aut 
700 1 |a Böttcher-Haberzeth, Sophie  |d 1976-  |e VerfasserIn  |0 (DE-588)1151462675  |0 (DE-627)1011807688  |0 (DE-576)497766981  |4 aut 
773 0 8 |i Enthalten in  |t Journal of burn care & research  |d Philadelphia, Pa. : Lippincott Williams & Wilkins, 2006  |g (2024), Artikel-ID irae150, Seite 1-9  |h Online-Ressource  |w (DE-627)341912352  |w (DE-600)2071028-8  |w (DE-576)263808653  |x 1559-0488  |7 nnas  |a Long-term outcomes of a cultured autologous dermo-epidermal skin substitute in children 5-year results of a phase I clinical trial 
773 1 8 |g year:2024  |g elocationid:irae150  |g pages:1-9  |g extent:9  |a Long-term outcomes of a cultured autologous dermo-epidermal skin substitute in children 5-year results of a phase I clinical trial 
856 4 0 |u https://doi.org/10.1093/jbcr/irae150  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20241008 
993 |a Article 
994 |a 2024 
998 |g 1094920886  |a Elrod, Julia  |m 1094920886:Elrod, Julia  |d 60000  |d 62200  |e 60000PE1094920886  |e 62200PE1094920886  |k 0/60000/  |k 1/60000/62200/  |p 6 
999 |a KXP-PPN1905080158  |e 4589053608 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title":"Long-term outcomes of a cultured autologous dermo-epidermal skin substitute in children","subtitle":"5-year results of a phase I clinical trial","title_sort":"Long-term outcomes of a cultured autologous dermo-epidermal skin substitute in children"}],"person":[{"role":"aut","family":"Schiestl","roleDisplay":"VerfasserIn","given":"Clemens","display":"Schiestl, Clemens"},{"role":"aut","roleDisplay":"VerfasserIn","given":"Kathrin","display":"Neuhaus, Kathrin","family":"Neuhaus"},{"role":"aut","family":"Meuli","given":"Martin","roleDisplay":"VerfasserIn","display":"Meuli, Martin"},{"role":"aut","family":"Farkas","given":"Melinda","roleDisplay":"VerfasserIn","display":"Farkas, Melinda"},{"role":"aut","given":"Fabienne","roleDisplay":"VerfasserIn","display":"Hartmann-Fritsch, Fabienne","family":"Hartmann-Fritsch"},{"role":"aut","given":"Julia","roleDisplay":"VerfasserIn","display":"Elrod, Julia","family":"Elrod"},{"role":"aut","given":"Jenny","roleDisplay":"VerfasserIn","display":"Bressan, Jenny","family":"Bressan"},{"role":"aut","family":"Reichmann","roleDisplay":"VerfasserIn","given":"Ernst","display":"Reichmann, Ernst"},{"role":"aut","display":"Böttcher-Haberzeth, Sophie","roleDisplay":"VerfasserIn","given":"Sophie","family":"Böttcher-Haberzeth"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"name":{"displayForm":["Clemens Schiestl, MD, Kathrin Neuhaus, MD, Martin Meuli, MD, Melinda Farkas, PhD, Fabienne Hartmann-Fritsch, PhD, Julia Elrod, MD, Jenny Bressan, Ernst Reichmann, PhD, Sophie Böttcher-Haberzeth, MD"]},"recId":"1905080158","id":{"eki":["1905080158"],"doi":["10.1093/jbcr/irae150"]},"language":["eng"],"note":["Gesehen am 08.10.2024"],"physDesc":[{"extent":"9 S.","noteIll":"Illustrationen"}],"relHost":[{"pubHistory":["Volume 27, issue 1 (January/February 2006)-"],"origin":[{"dateIssuedDisp":"2006-","publisher":"Lippincott Williams & Wilkins ; Oxford University Press","publisherPlace":"Philadelphia, Pa. ; Oxford","dateIssuedKey":"2006"}],"id":{"zdb":["2071028-8"],"eki":["341912352"],"issn":["1559-0488"]},"recId":"341912352","language":["eng"],"disp":"Long-term outcomes of a cultured autologous dermo-epidermal skin substitute in children 5-year results of a phase I clinical trialJournal of burn care & research","title":[{"title_sort":"Journal of burn care & research","subtitle":"official journal of the American Burn Association","title":"Journal of burn care & research"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"part":{"pages":"1-9","year":"2024","text":"(2024), Artikel-ID irae150, Seite 1-9","extent":"9"},"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 22.07.25"]}],"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"08 August 2024"}]} 
SRT |a SCHIESTLCLLONGTERMOU0820